Reporting adverse reactions to marketed health products : guidance document for industry.: H164-33/2018E-PDF
"This guidance document provides market authorization holders (MAHs) with assistance on how to comply with the Food and Drugs Act, the Food and Drug Regulations, and the Natural Health Products Regulations with respect to reporting adverse reactions (ARs) to marketed health products"--Scope, p. 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.800062&sl=0
| Department/Agency | Canada. Health Canada. |
|---|---|
| Title | Reporting adverse reactions to marketed health products : guidance document for industry. |
| Variant title | Guidance document for industry |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Earlier edition | Guidance document for industry - reporting adverse reactions to marketed health products |
| Format | Electronic |
| Electronic document | |
| Note(s) | "Effective Date: May 23, 2018." Title from cover. "Your health and safety ... our priority." "MedEffect Canada. Together we can improve health product safety." Issued also in French under title: Déclaration des effets indésirables des produits de santé commercialisés : document d'orientation à l'intention de l'industrie. Includes bibliographical references. |
| Publishing information | Ottawa : Health Canada, 2018. |
| Description | iv, 37 p. |
| ISBN | 978-0-660-01962-8 |
| Catalogue number |
|
| Departmental catalogue number | Pub.: 180052 |
| Subject terms | Side effects Health hazards Industrial policy |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: